Centessa Pharmaceuticals Plc Stock Probability of Future Stock Price Finishing Under 14.16
| CNTA Stock | USD 17.91 0.31 1.76% |
Centessa |
Centessa Pharmaceuticals Target Price Odds to finish below 14.16
The tendency of Centessa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 14.16 or more in 90 days |
| 17.91 | 90 days | 14.16 | about 6.56 |
Based on a normal probability distribution, the odds of Centessa Pharmaceuticals to drop to $ 14.16 or more in 90 days from now is about 6.56 (This Centessa Pharmaceuticals PLC probability density function shows the probability of Centessa Stock to fall within a particular range of prices over 90 days) . Probability of Centessa Pharmaceuticals price to stay between $ 14.16 and its current price of $17.91 at the end of the 90-day period is about 90.73 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.08 suggesting Centessa Pharmaceuticals PLC market returns are sensitive to returns on the market. As the market goes up or down, Centessa Pharmaceuticals is expected to follow. Additionally Centessa Pharmaceuticals PLC has an alpha of 0.3403, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Centessa Pharmaceuticals Price Density |
| Price |
Predictive Modules for Centessa Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Centessa Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Centessa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Centessa Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Centessa Pharmaceuticals is not an exception. The market had few large corrections towards the Centessa Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Centessa Pharmaceuticals PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Centessa Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | 1.08 | |
σ | Overall volatility | 1.09 | |
Ir | Information ratio | 0.09 |
Centessa Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Centessa Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Centessa Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Centessa Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 6.85 M. Net Loss for the year was (151.09 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Centessa Pharmaceuticals PLC currently holds about 484.16 M in cash with (160.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.13. | |
| Centessa Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Centessa Pharmaceuticals CEO Saha Saurabh sells 5,450 in shares |
Centessa Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Centessa Stock often depends not only on the future outlook of the current and potential Centessa Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Centessa Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 96.2 M | |
| Cash And Short Term Investments | 256.5 M |
Centessa Pharmaceuticals Technical Analysis
Centessa Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Centessa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Centessa Pharmaceuticals PLC. In general, you should focus on analyzing Centessa Stock price patterns and their correlations with different microeconomic environments and drivers.
Centessa Pharmaceuticals Predictive Forecast Models
Centessa Pharmaceuticals' time-series forecasting models is one of many Centessa Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Centessa Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Centessa Pharmaceuticals
Checking the ongoing alerts about Centessa Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Centessa Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Centessa Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 6.85 M. Net Loss for the year was (151.09 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Centessa Pharmaceuticals PLC currently holds about 484.16 M in cash with (160.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.13. | |
| Centessa Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Centessa Pharmaceuticals CEO Saha Saurabh sells 5,450 in shares |
Check out Centessa Pharmaceuticals Backtesting, Centessa Pharmaceuticals Valuation, Centessa Pharmaceuticals Correlation, Centessa Pharmaceuticals Hype Analysis, Centessa Pharmaceuticals Volatility, Centessa Pharmaceuticals History as well as Centessa Pharmaceuticals Performance. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 0.065 | Return On Assets (0.20) | Return On Equity (0.43) |
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.